AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$OMDA

Gracey Craig sold $14K of OMDA

Gracey Craig (Chief Accounting Officer) sold 644 shares of Omada Health, Inc. (OMDA) at $21.73 on 2026-09-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Sep 11, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosed sale is routine and does not alter the company's fundamentals.

02

Market read

Minor insider sale with negligible market impact.

03

What to watch

Potential upcoming earnings or product announcements could make any insider activity more material.

Relevance 2/10Novelty 4/10Timing: filing after market close on 2026-09-11

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or distress.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Chief Accounting Officer Gracey Craig sold 644 shares for $13,995 via a 10b5-1 plan, reducing her stake to 14,412 shares.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

Sale amount <$15K and insider is a C-level officer; market typically discounts such minor disposals.

Market effects

Sector

No broader sector impact; Omada operates in digital health niche.

Regional

None; company is US‑based with limited regional exposure.

Global

Insignificant on a global scale.

Counterpoint

What could challenge this read

If the insider had a larger stake, the sale could signal concerns, but the tiny size suggests routine liquidity need.

Key entities

  • company
    Omada Health, Inc.

    US‑listed digital health company (ticker OMDA).

  • person
    Gracey Craig

    Chief Accounting Officer of Omada Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

OMDA insider trading history →

Related articles

$OMDAHigh

Omada Health Earnings Call Signals Strong Growth Ahead

Omada Health (OMDA) reported Q3 revenue of $91M, up 34% YoY, with GAAP net income of $7M vs. a loss last year. Adjusted EBITDA rose to $12M. Management raised 2026 revenue guidance to $344M-$346M and adjusted EBITDA to $32M-$34M, citing strong demand for diabetes and hypertension programs. The company expects Q4 seasonality and GLP-1 coverage uncertainty.

tipranks.com
$OMDAMed

What Omada Health (OMDA) Said on Its Q3 Earnings Call

Omada Health (OMDA) expects Q4 revenue to decline due to seasonal factors, with adjusted EBITDA also moderating. The company ended Q3 with $243M in cash and no debt. CEO Sean Duffy will transition to executive chair in 2027, with Shao taking over as CEO. Omada's GLP-1 Care Track showed a 6% average weight loss at 12 weeks, according to peer-reviewed research.

finance.yahoo.com
$OMDAMedAI 8/10

Omada Health Inc (OMDA) (Q3 2026) Earnings Call Highlights: Record Revenue, Membership

Omada Health Inc (OMDA) reported record revenue and membership growth in Q3 2026. However, new enrollments are expected to decline in Q4 due to seasonality and tough comparisons. GLP-1 market dynamics and rising healthcare costs create uncertainty for 2027. Adjusted EBITDA is expected to moderate due to increased R&D and staffing. The company aims for 20%+ growth in 2027 through expanding covered lives, improving enrollment rates, and increasing engagement.

finance.yahoo.com